JP5053639B2 - 組織の蛍光発光を用いた糖化最終産物または疾病状態の尺度の決定 - Google Patents
組織の蛍光発光を用いた糖化最終産物または疾病状態の尺度の決定 Download PDFInfo
- Publication number
- JP5053639B2 JP5053639B2 JP2006538173A JP2006538173A JP5053639B2 JP 5053639 B2 JP5053639 B2 JP 5053639B2 JP 2006538173 A JP2006538173 A JP 2006538173A JP 2006538173 A JP2006538173 A JP 2006538173A JP 5053639 B2 JP5053639 B2 JP 5053639B2
- Authority
- JP
- Japan
- Prior art keywords
- tissue
- fluorescence
- wavelength
- light
- determining
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 201000010099 disease Diseases 0.000 title claims description 60
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims description 60
- 239000007795 chemical reaction product Substances 0.000 title claims description 30
- 230000036252 glycation Effects 0.000 title claims description 25
- 238000000034 method Methods 0.000 claims description 102
- 230000005284 excitation Effects 0.000 claims description 87
- 238000005259 measurement Methods 0.000 claims description 52
- 238000001514 detection method Methods 0.000 claims description 42
- 102000008186 Collagen Human genes 0.000 claims description 34
- 108010035532 Collagen Proteins 0.000 claims description 34
- 229920001436 collagen Polymers 0.000 claims description 34
- 239000000126 substance Substances 0.000 claims description 33
- 230000008859 change Effects 0.000 claims description 31
- 238000004458 analytical method Methods 0.000 claims description 12
- AYEKKSTZQYEZPU-RYUDHWBXSA-N pentosidine Chemical compound OC(=O)[C@@H](N)CCCCN1C=CC=C2N=C(NCCC[C@H](N)C(O)=O)N=C12 AYEKKSTZQYEZPU-RYUDHWBXSA-N 0.000 claims description 10
- RRUYWEMUWIRRNB-LURJTMIESA-N (2s)-6-amino-2-[carboxy(methyl)amino]hexanoic acid Chemical compound OC(=O)N(C)[C@H](C(O)=O)CCCCN RRUYWEMUWIRRNB-LURJTMIESA-N 0.000 claims description 9
- 238000005286 illumination Methods 0.000 claims description 8
- 230000004044 response Effects 0.000 claims description 8
- BOOXYSZJUWVNRE-JEDNCBNOSA-N (2s)-2,6-diaminohexanoic acid;2-oxopropanal Chemical class CC(=O)C=O.NCCCC[C@H](N)C(O)=O BOOXYSZJUWVNRE-JEDNCBNOSA-N 0.000 claims description 5
- ALXLJPPLHFRKEJ-MLWJPKLSSA-N (2s)-2,6-diaminononanedioic acid Chemical compound OC(=O)CCC(N)CCC[C@H](N)C(O)=O ALXLJPPLHFRKEJ-MLWJPKLSSA-N 0.000 claims description 5
- CAAMSDWKXXPUJR-UHFFFAOYSA-N 3,5-dihydro-4H-imidazol-4-one Chemical compound O=C1CNC=N1 CAAMSDWKXXPUJR-UHFFFAOYSA-N 0.000 claims description 5
- 230000002641 glycemic effect Effects 0.000 claims description 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 5
- VTYFITADLSVOAS-NSHDSACASA-N 1-(L-norleucin-6-yl)pyrraline Chemical compound OC(=O)[C@@H](N)CCCCN1C(CO)=CC=C1C=O VTYFITADLSVOAS-NSHDSACASA-N 0.000 claims description 4
- 230000001678 irradiating effect Effects 0.000 claims 6
- 229920002160 Celluloid Polymers 0.000 claims 2
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N alpha-ketodiacetal Natural products O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 claims 2
- 229940015043 glyoxal Drugs 0.000 claims 2
- 150000008248 threosides Chemical class 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 description 135
- 206010012601 diabetes mellitus Diseases 0.000 description 101
- 239000000835 fiber Substances 0.000 description 55
- 210000003491 skin Anatomy 0.000 description 45
- 238000012360 testing method Methods 0.000 description 39
- 230000003287 optical effect Effects 0.000 description 33
- 238000001228 spectrum Methods 0.000 description 29
- 238000012549 training Methods 0.000 description 29
- 239000000523 sample Substances 0.000 description 28
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 26
- 239000008103 glucose Substances 0.000 description 25
- 238000012937 correction Methods 0.000 description 21
- 238000002189 fluorescence spectrum Methods 0.000 description 20
- 238000010586 diagram Methods 0.000 description 16
- 239000008280 blood Substances 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 14
- 230000008569 process Effects 0.000 description 14
- 230000003595 spectral effect Effects 0.000 description 14
- 239000013307 optical fiber Substances 0.000 description 13
- 238000004611 spectroscopical analysis Methods 0.000 description 13
- 238000007410 oral glucose tolerance test Methods 0.000 description 12
- 238000004422 calculation algorithm Methods 0.000 description 10
- 230000000875 corresponding effect Effects 0.000 description 10
- 238000001506 fluorescence spectroscopy Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 238000002310 reflectometry Methods 0.000 description 9
- 238000012216 screening Methods 0.000 description 9
- 210000004207 dermis Anatomy 0.000 description 8
- 238000013145 classification model Methods 0.000 description 7
- 210000000245 forearm Anatomy 0.000 description 7
- 238000003780 insertion Methods 0.000 description 7
- 230000037431 insertion Effects 0.000 description 7
- 238000009825 accumulation Methods 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 238000002790 cross-validation Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000000691 measurement method Methods 0.000 description 5
- 238000000513 principal component analysis Methods 0.000 description 5
- 238000011002 quantification Methods 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 239000013598 vector Substances 0.000 description 5
- 208000002249 Diabetes Complications Diseases 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000004891 communication Methods 0.000 description 4
- 238000000695 excitation spectrum Methods 0.000 description 4
- 201000001421 hyperglycemia Diseases 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 230000010287 polarization Effects 0.000 description 4
- 238000000985 reflectance spectrum Methods 0.000 description 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 4
- 206010018429 Glucose tolerance impaired Diseases 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- 229920000995 Spectralon Polymers 0.000 description 3
- 239000012491 analyte Substances 0.000 description 3
- 238000013528 artificial neural network Methods 0.000 description 3
- 238000007385 chemical modification Methods 0.000 description 3
- 238000000556 factor analysis Methods 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 208000017169 kidney disease Diseases 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 201000009104 prediabetes syndrome Diseases 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- 108010005094 Advanced Glycation End Products Proteins 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010012655 Diabetic complications Diseases 0.000 description 2
- 206010061818 Disease progression Diseases 0.000 description 2
- 208000001280 Prediabetic State Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000007635 classification algorithm Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 230000005750 disease progression Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000295 emission spectrum Methods 0.000 description 2
- 238000000198 fluorescence anisotropy Methods 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 238000013178 mathematical model Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical class C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 description 2
- 238000010238 partial least squares regression Methods 0.000 description 2
- 238000007781 pre-processing Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000012628 principal component regression Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000007388 punch biopsy Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000007390 skin biopsy Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- 208000030090 Acute Disease Diseases 0.000 description 1
- 208000023514 Barrett esophagus Diseases 0.000 description 1
- 208000023665 Barrett oesophagus Diseases 0.000 description 1
- 208000014311 Cushing syndrome Diseases 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 208000002705 Glucose Intolerance Diseases 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 206010023230 Joint stiffness Diseases 0.000 description 1
- 238000000342 Monte Carlo simulation Methods 0.000 description 1
- 241000428199 Mustelinae Species 0.000 description 1
- 238000004497 NIR spectroscopy Methods 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 238000001069 Raman spectroscopy Methods 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 208000026062 Tissue disease Diseases 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000003705 background correction Methods 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000746 body region Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000023077 detection of light stimulus Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 208000002296 eclampsia Diseases 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000020937 fasting conditions Nutrition 0.000 description 1
- 208000004104 gestational diabetes Diseases 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 108091005995 glycated hemoglobin Proteins 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000012886 linear function Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000007477 logistic regression Methods 0.000 description 1
- 238000010801 machine learning Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000036564 melanin content Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000012014 optical coherence tomography Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 201000009395 primary hyperaldosteronism Diseases 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 238000012887 quadratic function Methods 0.000 description 1
- 238000013102 re-test Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000001055 reflectance spectroscopy Methods 0.000 description 1
- 238000012502 risk assessment Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0062—Arrangements for scanning
- A61B5/0064—Body surface scanning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0062—Arrangements for scanning
- A61B5/0066—Optical coherence imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0062—Arrangements for scanning
- A61B5/0068—Confocal scanning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/412—Detecting or monitoring sepsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optics & Photonics (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51534303P | 2003-10-28 | 2003-10-28 | |
| US60/515,343 | 2003-10-28 | ||
| US10/972,173 US7139598B2 (en) | 2002-04-04 | 2004-10-22 | Determination of a measure of a glycation end-product or disease state using tissue fluorescence |
| US10/972,173 | 2004-10-22 | ||
| PCT/US2004/035462 WO2005045393A2 (en) | 2003-10-28 | 2004-10-26 | Determination of a measure of a glycation end-product or disease state using tissue fluorescence |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007119053A Division JP5053699B2 (ja) | 2003-10-28 | 2007-04-27 | 組織の蛍光発光を用いた糖化最終産物または疾病状態の尺度の決定 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007510159A JP2007510159A (ja) | 2007-04-19 |
| JP2007510159A5 JP2007510159A5 (enExample) | 2007-10-11 |
| JP5053639B2 true JP5053639B2 (ja) | 2012-10-17 |
Family
ID=34576761
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006538173A Expired - Fee Related JP5053639B2 (ja) | 2003-10-28 | 2004-10-26 | 組織の蛍光発光を用いた糖化最終産物または疾病状態の尺度の決定 |
| JP2007119053A Expired - Fee Related JP5053699B2 (ja) | 2003-10-28 | 2007-04-27 | 組織の蛍光発光を用いた糖化最終産物または疾病状態の尺度の決定 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007119053A Expired - Fee Related JP5053699B2 (ja) | 2003-10-28 | 2007-04-27 | 組織の蛍光発光を用いた糖化最終産物または疾病状態の尺度の決定 |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US7139598B2 (enExample) |
| EP (1) | EP1686888A4 (enExample) |
| JP (2) | JP5053639B2 (enExample) |
| KR (2) | KR20130014646A (enExample) |
| CN (1) | CN102697510B (enExample) |
| CA (1) | CA2544204C (enExample) |
| WO (1) | WO2005045393A2 (enExample) |
Families Citing this family (239)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60141090D1 (de) | 2000-10-30 | 2010-03-04 | Gen Hospital Corp | Optische systeme zur gewebeanalyse |
| US9295391B1 (en) | 2000-11-10 | 2016-03-29 | The General Hospital Corporation | Spectrally encoded miniature endoscopic imaging probe |
| US20110313296A9 (en) * | 2001-04-11 | 2011-12-22 | Johnson Robert D | Method and Apparatus for Determination of a Measure of a Glycation End-Product or Disease State Using Tissue Fluorescence |
| US20070276199A1 (en) * | 2002-04-04 | 2007-11-29 | Ediger Marwood N | Determination of a Measure of a Glycation End-Product or Disease State Using Tissue Fluorescence |
| US7139598B2 (en) * | 2002-04-04 | 2006-11-21 | Veralight, Inc. | Determination of a measure of a glycation end-product or disease state using tissue fluorescence |
| US7865231B2 (en) | 2001-05-01 | 2011-01-04 | The General Hospital Corporation | Method and apparatus for determination of atherosclerotic plaque type by measurement of tissue optical properties |
| US7202947B2 (en) * | 2001-12-19 | 2007-04-10 | Wisconsin Alumni Research Foundation | Depth-resolved fluorescence instrument with angled excitation |
| US7355716B2 (en) | 2002-01-24 | 2008-04-08 | The General Hospital Corporation | Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands |
| US8131332B2 (en) * | 2002-04-04 | 2012-03-06 | Veralight, Inc. | Determination of a measure of a glycation end-product or disease state using tissue fluorescence of various sites |
| US8676283B2 (en) * | 2002-04-04 | 2014-03-18 | Veralight, Inc. | Method and apparatus to compensate for melanin and hemoglobin variation in determination of a measure of a glycation end-product or disease state using tissue fluorescence |
| US8140147B2 (en) * | 2002-04-04 | 2012-03-20 | Veralight, Inc. | Determination of a measure of a glycation end-product or disease state using a flexible probe to determine tissue fluorescence of various sites |
| US20120078075A1 (en) * | 2002-04-04 | 2012-03-29 | Maynard John D | Determination of a measure of a glycation end-product or disease state using tissue fluorescence in combination with one or more other tests |
| US20040124366A1 (en) * | 2002-10-02 | 2004-07-01 | Haishan Zeng | Apparatus and methods relating to high speed spectroscopy and excitation-emission matrices |
| US7761139B2 (en) | 2003-01-24 | 2010-07-20 | The General Hospital Corporation | System and method for identifying tissue using low-coherence interferometry |
| US7643153B2 (en) | 2003-01-24 | 2010-01-05 | The General Hospital Corporation | Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands |
| CA2519937C (en) | 2003-03-31 | 2012-11-20 | Guillermo J. Tearney | Speckle reduction in optical coherence tomography by path length encoded angular compounding |
| KR101204370B1 (ko) | 2003-06-06 | 2012-11-23 | 더 제너럴 하스피탈 코포레이션 | 파장 동조 소스용 방법 및 장치 |
| WO2005047813A1 (en) | 2003-10-27 | 2005-05-26 | The General Hospital Corporation | Method and apparatus for performing optical imaging using frequency-domain interferometry |
| US20080319286A1 (en) * | 2004-05-24 | 2008-12-25 | Trent Ridder | Optical Probes for Non-Invasive Analyte Measurements |
| WO2005117534A2 (en) | 2004-05-29 | 2005-12-15 | The General Hospital Corporation | Process, system and software arrangement for a chromatic dispersion compensation using reflective layers in optical coherence tomography (oct) imaging |
| WO2006009906A2 (en) * | 2004-06-17 | 2006-01-26 | The Regents Of The University Of California | Time-resolved non-invasive autofluorescence device for detecting diabetes |
| WO2006009910A2 (en) * | 2004-06-17 | 2006-01-26 | The Regents Of The University Of California | Time-resolved optometric fluorescence detection for skin diagnostics |
| JP4995720B2 (ja) | 2004-07-02 | 2012-08-08 | ザ ジェネラル ホスピタル コーポレイション | ダブルクラッドファイバを有する内視鏡撮像プローブ |
| JP5053845B2 (ja) | 2004-08-06 | 2012-10-24 | ザ ジェネラル ホスピタル コーポレイション | 光学コヒーレンス断層撮影法を使用して試料中の少なくとも１つの位置を決定するための方法、システムおよびソフトウェア装置 |
| ATE538714T1 (de) | 2004-08-24 | 2012-01-15 | Gen Hospital Corp | Verfahren, system und software-anordnung zur bestimmung des elastizitätsmoduls |
| JP5324095B2 (ja) | 2004-08-24 | 2013-10-23 | ザ ジェネラル ホスピタル コーポレイション | 血管セグメントを画像化する方法および装置 |
| KR101269455B1 (ko) | 2004-09-10 | 2013-05-30 | 더 제너럴 하스피탈 코포레이션 | 광 간섭 영상화를 위한 시스템 및 방법 |
| EP1804638B1 (en) | 2004-09-29 | 2012-12-19 | The General Hospital Corporation | System and method for optical coherence imaging |
| EP1825214A1 (en) | 2004-11-24 | 2007-08-29 | The General Hospital Corporation | Common-path interferometer for endoscopic oct |
| EP1816949A1 (en) | 2004-11-29 | 2007-08-15 | The General Hospital Corporation | Arrangements, devices, endoscopes, catheters and methods for performing optical imaging by simultaneously illuminating and detecting multiple points on a sample |
| US20070103678A1 (en) * | 2005-02-14 | 2007-05-10 | Sterling Bernhard B | Analyte detection system with interferent identification and correction |
| WO2006094168A1 (en) | 2005-03-01 | 2006-09-08 | Masimo Laboratories, Inc. | Noninvasive multi-parameter patient monitor |
| US8351665B2 (en) * | 2005-04-28 | 2013-01-08 | The General Hospital Corporation | Systems, processes and software arrangements for evaluating information associated with an anatomical structure by an optical coherence ranging technique |
| EP1889037A2 (en) | 2005-06-01 | 2008-02-20 | The General Hospital Corporation | Apparatus, method and system for performing phase-resolved optical frequency domain imaging |
| US20070167836A1 (en) * | 2005-07-25 | 2007-07-19 | Massachusetts Institute Of Technology | Multi modal spectroscopy |
| EP1913332B1 (en) | 2005-08-09 | 2010-10-13 | The General Hospital Corporation | Apparatus and method for performing polarization-based quadrature demodulation in optical coherence tomography |
| US20070121196A1 (en) | 2005-09-29 | 2007-05-31 | The General Hospital Corporation | Method and apparatus for method for viewing and analyzing of one or more biological samples with progressively increasing resolutions |
| US7889348B2 (en) | 2005-10-14 | 2011-02-15 | The General Hospital Corporation | Arrangements and methods for facilitating photoluminescence imaging |
| DK1968648T3 (en) | 2005-12-16 | 2015-07-27 | Amit Shachaf | Diagnostic system for the detection and diagnosis of skin cancer |
| WO2007082228A1 (en) | 2006-01-10 | 2007-07-19 | The General Hospital Corporation | Systems and methods for generating data based on one or more spectrally-encoded endoscopy techniques |
| WO2007084903A2 (en) | 2006-01-19 | 2007-07-26 | The General Hospital Corporation | Apparatus for obtaining information for a structure using spectrally-encoded endoscopy techniques and method for producing one or more optical arrangements |
| EP2289397A3 (en) | 2006-01-19 | 2011-04-06 | The General Hospital Corporation | Methods and systems for optical imaging of epithelial luminal organs by beam scanning thereof |
| WO2007149602A2 (en) | 2006-02-01 | 2007-12-27 | The General Hospital Corporation | Methods and systems for providing electromagnetic radiation to at least one portion of a sample using conformal laser therapy procedures |
| EP1986545A2 (en) | 2006-02-01 | 2008-11-05 | The General Hospital Corporation | Apparatus for applying a plurality of electro-magnetic radiations to a sample |
| JP5519152B2 (ja) | 2006-02-08 | 2014-06-11 | ザ ジェネラル ホスピタル コーポレイション | 光学顕微鏡法を用いて解剖学的サンプルに関わる情報を取得するための装置 |
| WO2007101026A2 (en) | 2006-02-24 | 2007-09-07 | The General Hospital Corporation | Methods and systems for performing angle-resolved fourier-domain optical coherence tomography |
| EP2015669A2 (en) | 2006-05-10 | 2009-01-21 | The General Hospital Corporation | Processes, arrangements and systems for providing frequency domain imaging of a sample |
| US7920271B2 (en) | 2006-08-25 | 2011-04-05 | The General Hospital Corporation | Apparatus and methods for enhancing optical coherence tomography imaging using volumetric filtering techniques |
| US8265723B1 (en) | 2006-10-12 | 2012-09-11 | Cercacor Laboratories, Inc. | Oximeter probe off indicator defining probe off space |
| US8838213B2 (en) | 2006-10-19 | 2014-09-16 | The General Hospital Corporation | Apparatus and method for obtaining and providing imaging information associated with at least one portion of a sample, and effecting such portion(s) |
| US8155730B2 (en) * | 2006-10-24 | 2012-04-10 | The Research Foundation Of State University Of New York | Composition, method, system, and kit for optical electrophysiology |
| WO2008052221A2 (en) * | 2006-10-27 | 2008-05-02 | Aretais, Inc. | Use of coherent raman techniques for medical diagnostic and therapeutic purposes, and calibration techniques for same |
| DE102006050885B4 (de) * | 2006-10-27 | 2016-11-03 | Siemens Healthcare Gmbh | Vorrichtung zur Erzeugung von Gewebeschnittbildern |
| US7949019B2 (en) | 2007-01-19 | 2011-05-24 | The General Hospital | Wavelength tuning source based on a rotatable reflector |
| US20080221418A1 (en) * | 2007-03-09 | 2008-09-11 | Masimo Corporation | Noninvasive multi-parameter patient monitor |
| US9176319B2 (en) | 2007-03-23 | 2015-11-03 | The General Hospital Corporation | Methods, arrangements and apparatus for utilizing a wavelength-swept laser using angular scanning and dispersion procedures |
| EP2476369B1 (en) | 2007-03-27 | 2014-10-01 | Masimo Laboratories, Inc. | Multiple wavelength optical sensor |
| US10534129B2 (en) | 2007-03-30 | 2020-01-14 | The General Hospital Corporation | System and method providing intracoronary laser speckle imaging for the detection of vulnerable plaque |
| US8045177B2 (en) | 2007-04-17 | 2011-10-25 | The General Hospital Corporation | Apparatus and methods for measuring vibrations using spectrally-encoded endoscopy |
| US8374665B2 (en) | 2007-04-21 | 2013-02-12 | Cercacor Laboratories, Inc. | Tissue profile wellness monitor |
| US7803217B2 (en) * | 2007-04-24 | 2010-09-28 | Arizant Healthcare, Inc. | Bubble trap for high flow rate infusion |
| WO2008133551A1 (en) * | 2007-04-27 | 2008-11-06 | St. Jude Medical Ab | Implantable concentration sensor and device |
| US8417311B2 (en) | 2008-09-12 | 2013-04-09 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
| US7972296B2 (en) | 2007-10-10 | 2011-07-05 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
| US7873397B2 (en) * | 2007-06-19 | 2011-01-18 | Richard Higgins | Spectroscopic optical system |
| WO2009018456A2 (en) | 2007-07-31 | 2009-02-05 | The General Hospital Corporation | Systems and methods for providing beam scan patterns for high speed doppler optical frequency domain imaging |
| DE102007053074A1 (de) * | 2007-08-03 | 2009-05-14 | Carl Zeiss Meditec Ag | Verfahren und Messeinrichtung zur Fluoreszenzmessung am Auge |
| WO2009059034A1 (en) | 2007-10-30 | 2009-05-07 | The General Hospital Corporation | System and method for cladding mode detection |
| US8280471B2 (en) | 2007-12-12 | 2012-10-02 | Kimberly-Clark Worldwide, Inc. | Fiber optic based detection of autofluorescent bacterial pathogens |
| JP5147379B2 (ja) * | 2007-12-18 | 2013-02-20 | 花王株式会社 | メラニン分布可視化方法及びその装置 |
| JP5193612B2 (ja) * | 2008-01-22 | 2013-05-08 | 浜松ホトニクス株式会社 | 疾患判定方法、疾患判定装置、疾患判定用データ生成方法及び疾患判定用データ生成装置 |
| US7898656B2 (en) | 2008-04-30 | 2011-03-01 | The General Hospital Corporation | Apparatus and method for cross axis parallel spectroscopy |
| JP5607610B2 (ja) | 2008-05-07 | 2014-10-15 | ザ ジェネラル ホスピタル コーポレイション | 構造の特徴を決定する装置、装置の作動方法およびコンピュータアクセス可能な媒体 |
| CA2724973C (en) | 2008-05-20 | 2015-08-11 | University Health Network | Device and method for fluorescence-based imaging and monitoring |
| CN102046072B (zh) * | 2008-05-26 | 2013-04-24 | 阿克苏医学影像有限公司 | 光学检测方法和用于光学检测关节状况的设备 |
| JP5795531B2 (ja) | 2008-06-20 | 2015-10-14 | ザ ジェネラル ホスピタル コーポレイション | フューズドファイバオプティックカプラ構造、及びその使用方法 |
| US20100003664A1 (en) * | 2008-07-01 | 2010-01-07 | Lou Reinisch | System for Glycated Protein Detection |
| WO2010002278A1 (en) * | 2008-07-01 | 2010-01-07 | Glyvale Limited | System for glycated protein detection |
| EP2309923B1 (en) | 2008-07-14 | 2020-11-25 | The General Hospital Corporation | Apparatus and methods for color endoscopy |
| US7959598B2 (en) | 2008-08-20 | 2011-06-14 | Asante Solutions, Inc. | Infusion pump systems and methods |
| DE102008044883A1 (de) * | 2008-08-29 | 2010-03-04 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verfahren zur Messung der Lumineszenzstrahlung einer Halbleiterstruktur |
| JP5731394B2 (ja) | 2008-12-10 | 2015-06-10 | ザ ジェネラル ホスピタル コーポレイション | 光サブサンプリングを通じて、光コヒーレンストモグラヒィーのイメージング深度範囲を伸ばすためのシステム、装置及び方法 |
| US9615748B2 (en) | 2009-01-20 | 2017-04-11 | The General Hospital Corporation | Endoscopic biopsy apparatus, system and method |
| EP2382456A4 (en) | 2009-01-26 | 2012-07-25 | Gen Hospital Corp | SYSTEM, METHOD AND COMPUTER MEDIUM FOR MICROSCOPY WITH A WIDE FIELD AND VERY HIGH RESOLUTION |
| JP5303712B2 (ja) * | 2009-01-29 | 2013-10-02 | 和歌山県 | 下肢協調性評価システム |
| WO2010091190A2 (en) | 2009-02-04 | 2010-08-12 | The General Hospital Corporation | Apparatus and method for utilization of a high-speed optical wavelength tuning source |
| JP5311655B2 (ja) * | 2009-05-15 | 2013-10-09 | 独立行政法人農業・食品産業技術総合研究機構 | 成分分布分析方法および成分分布分析装置 |
| JP5215939B2 (ja) * | 2009-05-26 | 2013-06-19 | 株式会社日立ハイテクノロジーズ | 分光蛍光光度計および分光分析光度計 |
| CN102469943A (zh) | 2009-07-14 | 2012-05-23 | 通用医疗公司 | 用于测量脉管内流动和压力的设备、系统和方法 |
| JP5394501B2 (ja) | 2009-10-02 | 2014-01-22 | シャープ株式会社 | 血管状態モニタリング方法 |
| JP5536582B2 (ja) | 2009-10-22 | 2014-07-02 | 日本光電工業株式会社 | 生体パラメータ表示装置 |
| US8775096B2 (en) | 2009-10-29 | 2014-07-08 | Hoya Corporation | Auxiliary diagnostic apparatus and auxiliary diagnostic method |
| CA2781040A1 (en) * | 2009-11-17 | 2011-05-26 | Veralight, Inc. | Method and apparatus to detect coronary artery calcification or disease |
| US9839381B1 (en) | 2009-11-24 | 2017-12-12 | Cercacor Laboratories, Inc. | Physiological measurement system with automatic wavelength adjustment |
| DE112010004682T5 (de) | 2009-12-04 | 2013-03-28 | Masimo Corporation | Kalibrierung für mehrstufige physiologische Monitore |
| US9615747B2 (en) * | 2010-01-19 | 2017-04-11 | Access Business Group International Llc | Method for determining skin glycation |
| SMT202000624T1 (it) | 2010-03-05 | 2021-01-05 | Massachusetts Gen Hospital | Apparecchio per fornire radiazione elettromagnetica a un campione |
| US9173604B2 (en) | 2010-03-19 | 2015-11-03 | Sharp Kabushiki Kaisha | Measurement device, measurement method, measurement result processing device, measurement system, measurement result processing method, control program, and recording medium |
| US9069130B2 (en) | 2010-05-03 | 2015-06-30 | The General Hospital Corporation | Apparatus, method and system for generating optical radiation from biological gain media |
| US9557154B2 (en) | 2010-05-25 | 2017-01-31 | The General Hospital Corporation | Systems, devices, methods, apparatus and computer-accessible media for providing optical imaging of structures and compositions |
| EP2575598A2 (en) | 2010-05-25 | 2013-04-10 | The General Hospital Corporation | Apparatus, systems, methods and computer-accessible medium for spectral analysis of optical coherence tomography images |
| US10285568B2 (en) | 2010-06-03 | 2019-05-14 | The General Hospital Corporation | Apparatus and method for devices for imaging structures in or at one or more luminal organs |
| WO2011159148A2 (en) * | 2010-06-18 | 2011-12-22 | Diagnoptics Holding B.V. | Method and apparatus for determining an autofluorescence value of skin tissue. |
| JP5701528B2 (ja) * | 2010-07-16 | 2015-04-15 | オリンパス株式会社 | 生体状態量測定装置 |
| JP5384453B2 (ja) | 2010-09-09 | 2014-01-08 | シャープ株式会社 | 測定装置、測定システム、測定方法、制御プログラム、および、記録媒体 |
| JP5290257B2 (ja) | 2010-10-12 | 2013-09-18 | シャープ株式会社 | 検出装置、検出方法、制御プログラムおよび記録媒体 |
| WO2012058381A2 (en) * | 2010-10-27 | 2012-05-03 | The General Hospital Corporation | Apparatus, systems and methods for measuring blood pressure within at least one vessel |
| JP6012614B2 (ja) * | 2010-11-05 | 2016-10-25 | フリーダム メディテック インコーポレイテッド | 生体組織の構造的性質に影響する疾患を非侵襲的に検出するための装置および方法 |
| JP5770453B2 (ja) * | 2010-11-22 | 2015-08-26 | 八幡物産株式会社 | ローヤルゼリー含有組成物及びソフトカプセル |
| KR101243183B1 (ko) * | 2011-04-08 | 2013-03-14 | 한국전기연구원 | 최종당화산물의 자가형광 측정 장치 |
| JP5832783B2 (ja) * | 2011-05-26 | 2015-12-16 | シャープ株式会社 | 肌状態判定装置、肌状態判定プログラムおよび記録媒体 |
| JP5203488B2 (ja) * | 2011-05-26 | 2013-06-05 | シャープ株式会社 | 測定装置および測定方法 |
| WO2013013049A1 (en) | 2011-07-19 | 2013-01-24 | The General Hospital Corporation | Systems, methods, apparatus and computer-accessible-medium for providing polarization-mode dispersion compensation in optical coherence tomography |
| WO2013029047A1 (en) | 2011-08-25 | 2013-02-28 | The General Hospital Corporation | Methods, systems, arrangements and computer-accessible medium for providing micro-optical coherence tomography procedures |
| EP2769491A4 (en) | 2011-10-18 | 2015-07-22 | Gen Hospital Corp | DEVICE AND METHOD FOR PRODUCING AND / OR PROVIDING RECIRCULATING OPTICAL DELAY (DE) |
| JP5970785B2 (ja) * | 2011-11-16 | 2016-08-17 | ソニー株式会社 | 生体計測装置、生体計測方法、プログラムおよび記録媒体 |
| US10006922B2 (en) | 2011-12-22 | 2018-06-26 | Massachusetts Institute Of Technology | Raman spectroscopy for detection of glycated analytes |
| KR101483087B1 (ko) * | 2012-03-21 | 2015-01-16 | 한국전기연구원 | 반사광 검출형 피부 형광 측정 장치 |
| US9155473B2 (en) * | 2012-03-21 | 2015-10-13 | Korea Electrotechnology Research Institute | Reflection detection type measurement apparatus for skin autofluorescence |
| KR101444730B1 (ko) * | 2012-03-21 | 2014-09-26 | 한국전기연구원 | 투과광 검출형 피부 형광 측정 장치 |
| KR101454298B1 (ko) * | 2013-01-29 | 2014-10-27 | 한국전기연구원 | 반사광 검출용 피라미드형 피부 형광 측정 장치 |
| US9723990B2 (en) | 2012-03-21 | 2017-08-08 | Korea Electro Technology Research Institute | Transmitted light detection type measurement apparatus for skin autofluorescence |
| KR101410739B1 (ko) * | 2012-07-09 | 2014-06-24 | 한국전기연구원 | 투과광 검출형 피부 형광 측정 장치 |
| US9955871B2 (en) | 2012-03-21 | 2018-05-01 | Korea Electrotechnology Research Institute | Transmitted light detection type measurement apparatus for skin autofluorescence |
| WO2013148306A1 (en) | 2012-03-30 | 2013-10-03 | The General Hospital Corporation | Imaging system, method and distal attachment for multidirectional field of view endoscopy |
| US11490797B2 (en) | 2012-05-21 | 2022-11-08 | The General Hospital Corporation | Apparatus, device and method for capsule microscopy |
| US9415550B2 (en) | 2012-08-22 | 2016-08-16 | The General Hospital Corporation | System, method, and computer-accessible medium for fabrication miniature endoscope using soft lithography |
| JP2014062740A (ja) * | 2012-09-19 | 2014-04-10 | Sharp Corp | 老化評価方法および老化評価装置 |
| WO2014117130A1 (en) | 2013-01-28 | 2014-07-31 | The General Hospital Corporation | Apparatus and method for providing diffuse spectroscopy co-registered with optical frequency domain imaging |
| WO2014120791A1 (en) | 2013-01-29 | 2014-08-07 | The General Hospital Corporation | Apparatus, systems and methods for providing information regarding the aortic valve |
| US11179028B2 (en) | 2013-02-01 | 2021-11-23 | The General Hospital Corporation | Objective lens arrangement for confocal endomicroscopy |
| WO2014144709A2 (en) | 2013-03-15 | 2014-09-18 | The General Hospital Corporation | Methods and systems for characterizing an object |
| WO2014172467A1 (en) | 2013-04-16 | 2014-10-23 | Smartloop Llc | Discretionary insulin delivery systems and methods |
| US9784681B2 (en) | 2013-05-13 | 2017-10-10 | The General Hospital Corporation | System and method for efficient detection of the phase and amplitude of a periodic modulation associated with self-interfering fluorescence |
| JP6416887B2 (ja) * | 2013-05-15 | 2018-10-31 | ジ アドミニストレーターズ オブ ザ テュレーン エデュケーショナル ファンド | 構造化照明を用いた組織試料の顕微鏡観察 |
| JP6103700B2 (ja) * | 2013-05-15 | 2017-03-29 | 京都府公立大学法人 | ラマン散乱を用いた心臓組織の識別方法及び装置 |
| US9561324B2 (en) | 2013-07-19 | 2017-02-07 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
| WO2015009932A1 (en) | 2013-07-19 | 2015-01-22 | The General Hospital Corporation | Imaging apparatus and method which utilizes multidirectional field of view endoscopy |
| US10117576B2 (en) | 2013-07-19 | 2018-11-06 | The General Hospital Corporation | System, method and computer accessible medium for determining eye motion by imaging retina and providing feedback for acquisition of signals from the retina |
| WO2015013651A2 (en) | 2013-07-26 | 2015-01-29 | The General Hospital Corporation | System, apparatus and method utilizing optical dispersion for fourier-domain optical coherence tomography |
| WO2015105870A1 (en) | 2014-01-08 | 2015-07-16 | The General Hospital Corporation | Method and apparatus for microscopic imaging |
| GB2523989B (en) | 2014-01-30 | 2020-07-29 | Insulet Netherlands B V | Therapeutic product delivery system and method of pairing |
| US10736494B2 (en) | 2014-01-31 | 2020-08-11 | The General Hospital Corporation | System and method for facilitating manual and/or automatic volumetric imaging with real-time tension or force feedback using a tethered imaging device |
| JP5864639B2 (ja) | 2014-02-20 | 2016-02-17 | シャープ株式会社 | 測定装置 |
| CN103860145A (zh) * | 2014-03-27 | 2014-06-18 | 黄鹏 | 基于荧光检测方法的植入式检测装置 |
| WO2015153982A1 (en) | 2014-04-04 | 2015-10-08 | The General Hospital Corporation | Apparatus and method for controlling propagation and/or transmission of electromagnetic radiation in flexible waveguide(s) |
| JP5864674B2 (ja) | 2014-05-29 | 2016-02-17 | シャープ株式会社 | 測定プローブ、測定装置およびアタッチメント機構 |
| WO2016011534A1 (en) | 2014-07-24 | 2016-01-28 | University Health Network | Collection and analysis of data for diagnostic purposes |
| WO2016015052A1 (en) | 2014-07-25 | 2016-01-28 | The General Hospital Corporation | Apparatus, devices and methods for in vivo imaging and diagnosis |
| CA2977053C (en) | 2015-02-18 | 2023-08-01 | Insulet Corporation | Fluid delivery and infusion devices, and methods of use thereof |
| DE102015006406A1 (de) * | 2015-05-19 | 2016-12-08 | SAMTD GmbH & Co. KG | Verfahren und Vorrichtung zur nicht-invasiven Bestimmung einer Messgröße eines Analyten in einem biologischen Körper |
| JP6156804B2 (ja) * | 2015-06-09 | 2017-07-05 | シャープライフサイエンス株式会社 | 老化評価装置 |
| US20170038299A1 (en) * | 2015-08-07 | 2017-02-09 | Sentinel Monitoring Systems, Inc. | Online process monitoring |
| US20170280971A1 (en) | 2015-08-13 | 2017-10-05 | Hoya Corporation | Evaluation value calculation device and electronic endoscope system |
| WO2017026540A1 (ja) | 2015-08-13 | 2017-02-16 | Hoya株式会社 | 評価値計算装置及び電子内視鏡システム |
| KR101978838B1 (ko) * | 2015-11-02 | 2019-05-16 | 재단법인 아산사회복지재단 | 다중 파장 내시경 시스템 및 이를 이용한 영상 처리 방법 |
| KR102487983B1 (ko) | 2015-11-16 | 2023-01-11 | 삼성전자주식회사 | 질병 예측 모델 구축 장치 및 방법과 질병 예측 장치 |
| EP3374905A1 (en) | 2016-01-13 | 2018-09-19 | Bigfoot Biomedical, Inc. | User interface for diabetes management system |
| EP4545005A3 (en) | 2016-01-14 | 2025-07-02 | Insulet Corporation | Adjusting insulin delivery rates |
| HK1256995A1 (zh) | 2016-01-14 | 2019-10-11 | Bigfoot Biomedical, Inc. | 药物输送设备、系统和方法中的阻塞解决方案 |
| US12383166B2 (en) | 2016-05-23 | 2025-08-12 | Insulet Corporation | Insulin delivery system and methods with risk-based set points |
| KR102655736B1 (ko) * | 2016-07-19 | 2024-04-05 | 삼성전자주식회사 | 이종 스펙트럼 기반 혈당 추정 장치 및 방법 |
| WO2018058041A1 (en) | 2016-09-23 | 2018-03-29 | Insulet Corporation | Fluid delivery device with sensor |
| US10610088B2 (en) | 2016-10-18 | 2020-04-07 | The Asan Foundation | Multi-wavelength endoscopic system and image processing method using same |
| AU2017376111B2 (en) | 2016-12-12 | 2023-02-02 | Bigfoot Biomedical, Inc. | Alarms and alerts for medication delivery devices and related systems and methods |
| US10583250B2 (en) | 2017-01-13 | 2020-03-10 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| US10500334B2 (en) | 2017-01-13 | 2019-12-10 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| EP4708311A3 (en) | 2017-01-13 | 2026-05-20 | Insulet Corporation | METHODS, SYSTEMS AND DEVICES FOR INSULIN ADMINISTRATION |
| EP4708310A3 (en) | 2017-01-13 | 2026-05-06 | Insulet Corporation | Insulin delivery methods, systems and devices |
| US10758675B2 (en) | 2017-01-13 | 2020-09-01 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| US10881793B2 (en) | 2017-01-13 | 2021-01-05 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| AU2018265567A1 (en) * | 2017-05-11 | 2019-12-12 | Neolitics, Inc. | Adaptive optical analyzer with automatic drift control and high dynamic range |
| RU2663938C1 (ru) * | 2017-05-25 | 2018-08-13 | Общество с ограниченной ответственностью "БИОФОТОНИКА" | Устройство для оптической диагностики кровоснабжения и жизнеобеспечения биологических тканей |
| CN107242855A (zh) * | 2017-06-05 | 2017-10-13 | 天津大学 | 一种生物组织动态调制光谱测量装置及方法 |
| US12653426B2 (en) | 2017-07-13 | 2026-06-16 | Bigfoot Biomedical, Inc. | Multi-scale display of blood glucose information |
| KR102441334B1 (ko) | 2017-08-01 | 2022-09-06 | 삼성전자주식회사 | 생체 정보 처리 장치 및 방법 |
| KR102510174B1 (ko) | 2017-09-13 | 2023-03-14 | 삼성전자주식회사 | 질병 예측 모델 생성 장치, 질병 예측 장치 및 방법 |
| RU2688811C2 (ru) * | 2017-11-15 | 2019-05-22 | Федеральное государственное бюджетное образовательное учреждение высшего образования "ОРЛОВСКИЙ ГОСУДАРСТВЕННЫЙ УНИВЕРСИТЕТ имени И.С. ТУРГЕНЕВА" (ОГУ им. И.С. Тургенева) | Способ диагностики микроциркуляторно-тканевых нарушений в стопах пациентов с сахарным диабетом |
| US11039768B2 (en) | 2018-01-09 | 2021-06-22 | Medtronic Monitoring, Inc. | System and method for non-invasive monitoring of hemoglobin |
| US11154224B2 (en) | 2018-01-09 | 2021-10-26 | Medtronic Monitoring, Inc. | System and method for non-invasive monitoring of hematocrit concentration |
| US11051727B2 (en) | 2018-01-09 | 2021-07-06 | Medtronic Monitoring, Inc. | System and method for non-invasive monitoring of advanced glycation end-products (AGE) |
| RU2687775C1 (ru) * | 2018-01-10 | 2019-05-16 | Золтан Мойшевич Сигал | Устройство для диагностики органной патологии |
| US11330983B2 (en) | 2018-03-30 | 2022-05-17 | Samsung Electronics Co., Ltd. | Electronic device for acquiring state information on object, and control method therefor |
| USD928199S1 (en) | 2018-04-02 | 2021-08-17 | Bigfoot Biomedical, Inc. | Medication delivery device with icons |
| US11565043B2 (en) | 2018-05-04 | 2023-01-31 | Insulet Corporation | Safety constraints for a control algorithm based drug delivery system |
| US12562251B1 (en) | 2018-05-09 | 2026-02-24 | Bigfoot Biomedical, Inc. | Computing architecture for assuring the provenance of medication therapy related parameters, and related systems, methods and devices |
| AU2019347755B2 (en) | 2018-09-28 | 2023-02-02 | Insulet Corporation | Activity mode for artificial pancreas system |
| WO2020077223A1 (en) | 2018-10-11 | 2020-04-16 | Insulet Corporation | Event detection for drug delivery system |
| KR102640331B1 (ko) | 2018-10-19 | 2024-02-26 | 삼성전자주식회사 | 생체정보 추정 장치 및 방법과, 생체정보 추정 지원 장치 |
| USD920343S1 (en) | 2019-01-09 | 2021-05-25 | Bigfoot Biomedical, Inc. | Display screen or portion thereof with graphical user interface associated with insulin delivery |
| CN109793501A (zh) * | 2019-03-08 | 2019-05-24 | 合肥中科易康达生物医学有限公司 | 一种人体代谢健康指数无创检测设备 |
| KR102958763B1 (ko) | 2019-07-05 | 2026-04-30 | 주식회사 엘지생활건강 | 피부당화 정보에 기반한 피부상태 진단 시스템 및 이를 이용한 피부당화 정보에 기반한 추천 시스템 |
| US11801344B2 (en) | 2019-09-13 | 2023-10-31 | Insulet Corporation | Blood glucose rate of change modulation of meal and correction insulin bolus quantity |
| US11935637B2 (en) | 2019-09-27 | 2024-03-19 | Insulet Corporation | Onboarding and total daily insulin adaptivity |
| CN110790812A (zh) * | 2019-11-08 | 2020-02-14 | 安徽易康达光电科技有限公司 | 一种皮肤胆固醇检测的试剂及其制备方法 |
| KR20210069944A (ko) * | 2019-12-04 | 2021-06-14 | 삼성전자주식회사 | 노화도 추정 장치 및 방법 |
| EP4354455B1 (en) | 2019-12-06 | 2025-10-29 | Insulet Corporation | Techniques and devices providing adaptivity and personalization in diabetes treatment |
| US11833329B2 (en) | 2019-12-20 | 2023-12-05 | Insulet Corporation | Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns |
| WO2021141941A1 (en) | 2020-01-06 | 2021-07-15 | Insulet Corporation | Prediction of meal and/or exercise events based on persistent residuals |
| WO2021158580A1 (en) | 2020-02-03 | 2021-08-12 | Insulet Corporation | Use of fuzzy logic in predicting user behavior affecting blood glucose concentration |
| US11551802B2 (en) | 2020-02-11 | 2023-01-10 | Insulet Corporation | Early meal detection and calorie intake detection |
| US11547800B2 (en) | 2020-02-12 | 2023-01-10 | Insulet Corporation | User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system |
| US11986630B2 (en) | 2020-02-12 | 2024-05-21 | Insulet Corporation | Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk |
| US11324889B2 (en) | 2020-02-14 | 2022-05-10 | Insulet Corporation | Compensation for missing readings from a glucose monitor in an automated insulin delivery system |
| US12495994B2 (en) | 2020-02-20 | 2025-12-16 | Insulet Corporation | Meal bolus subcategories in model based insulin therapy |
| US11607493B2 (en) | 2020-04-06 | 2023-03-21 | Insulet Corporation | Initial total daily insulin setting for user onboarding |
| DE102020117043B3 (de) | 2020-06-29 | 2021-12-02 | Becker & Hickl Gmbh | Kurzzeitspektroskopie-Verfahren und Kurzzeitspektroskopie-Vorrichtung |
| KR102939012B1 (ko) * | 2020-07-09 | 2026-03-16 | 덴드라이트 이미징, 인코퍼레이티드 | 첨단 신경 조직 이미징 시스템 |
| US12121700B2 (en) | 2020-07-22 | 2024-10-22 | Insulet Corporation | Open-loop insulin delivery basal parameters based on insulin delivery records |
| US11684716B2 (en) | 2020-07-31 | 2023-06-27 | Insulet Corporation | Techniques to reduce risk of occlusions in drug delivery systems |
| US12569619B2 (en) | 2020-09-21 | 2026-03-10 | Insulet Corporation | Techniques for determining automated insulin delivery dosages |
| EP4696344A3 (en) | 2020-09-30 | 2026-04-15 | Insulet Corporation | Drug delivery device with integrated optical-based glucose monitor |
| US12115351B2 (en) | 2020-09-30 | 2024-10-15 | Insulet Corporation | Secure wireless communications between a glucose monitor and other devices |
| AU2021416188A1 (en) | 2020-12-31 | 2023-07-06 | Orlucent, Inc. | Systems and methods for assessing tissue remodeling |
| US11160925B1 (en) | 2021-01-29 | 2021-11-02 | Insulet Corporation | Automatic drug delivery system for delivery of a GLP-1 therapeutic |
| EP4285376A1 (en) | 2021-01-29 | 2023-12-06 | Insulet Corporation | Techniques and devices that adapt basal profiles for drug delivery applications |
| KR102658416B1 (ko) * | 2021-02-18 | 2024-04-18 | 주식회사 엔세이지 | 급성심근경색 환자의 혈중 age 분석 방법 및 이를 이용한 급성심근경색의 예후 예측방법 |
| US12636435B2 (en) | 2021-02-26 | 2026-05-26 | Insulet Corporation | Techniques for optimizing usage of an automatic drug delivery system |
| WO2022192482A1 (en) | 2021-03-10 | 2022-09-15 | Insulet Corporation | A medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions |
| US11904140B2 (en) | 2021-03-10 | 2024-02-20 | Insulet Corporation | Adaptable asymmetric medicament cost component in a control system for medicament delivery |
| US12592306B2 (en) | 2021-04-28 | 2026-03-31 | Insulet Corporation | Devices and methods for initialization of drug delivery devices using measured analyte sensor information |
| US12496398B2 (en) | 2021-05-28 | 2025-12-16 | Insulet Corporation | Threshold based automatic glucose control response |
| EP4101482A1 (en) | 2021-06-07 | 2022-12-14 | Insulet Corporation | Exercise safety prediction based on physiological conditions |
| US12514980B2 (en) | 2021-06-30 | 2026-01-06 | Insulet Corporation | Adjustment of medicament delivery by a medicament delivery device based on menstrual cycle phase |
| US12521486B2 (en) | 2021-07-16 | 2026-01-13 | Insulet Corporation | Method for modification of insulin delivery during pregnancy in automatic insulin delivery systems |
| US12653949B2 (en) | 2021-07-29 | 2026-06-16 | Insulet Corporation | Adaptation of medicament delivery in response to user stress load |
| WO2023012958A1 (ja) * | 2021-08-05 | 2023-02-09 | 株式会社島津製作所 | 情報処理システムおよび情報処理方法 |
| CN113791059A (zh) * | 2021-09-16 | 2021-12-14 | 大连理工大学 | 一种低背景信号的毛细管荧光仪 |
| EP4409581A1 (en) | 2021-09-27 | 2024-08-07 | Insulet Corporation | Techniques enabling adaptation of parameters in aid systems by user input |
| US11439754B1 (en) | 2021-12-01 | 2022-09-13 | Insulet Corporation | Optimizing embedded formulations for drug delivery |
| KR102733645B1 (ko) * | 2021-12-03 | 2024-11-26 | 주식회사 아이센스 | 생체값의 예측 방법 |
| WO2023150737A1 (en) | 2022-02-07 | 2023-08-10 | Insulet Corporation | Techniques for determining medication correction factors in automatic medication delivery systems |
| JP7893620B2 (ja) * | 2022-02-08 | 2026-07-22 | 旭化成メディカル株式会社 | 濃度算出装置及び血液処理システム並びに濃度算出方法 |
| EP4243030A1 (en) | 2022-03-09 | 2023-09-13 | Insulet Corporation | Adjusting medicament delivery parameters in an open loop medicament delivery mode |
| EP4511843A1 (en) | 2022-04-21 | 2025-02-26 | Insulet Corporation | Insulin adaptation and safety monitoring for sick day management |
| JP7754310B2 (ja) * | 2022-06-15 | 2025-10-15 | 株式会社島津製作所 | 推定方法、推定プログラム、および推定システム |
| EP4618828A1 (en) * | 2022-11-15 | 2025-09-24 | Biotronik Ag | An ai based system for monitoring of peripheral vascular disease patients |
| KR20250129777A (ko) | 2023-01-06 | 2025-08-29 | 인슐렛 코포레이션 | 후속 자동 안전 제약 완화를 갖는 자동으로 또는 수동으로 개시되는 음식 볼러스 전달 |
| CN116403661B (zh) * | 2023-04-14 | 2023-10-13 | 中南民族大学 | 一种基于美拉德反应产物荧光信号解析的高温大曲白酒鉴别和化合物预测方法 |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS52100277A (en) | 1976-02-19 | 1977-08-23 | Hitachi Ltd | Absorption photometer |
| US4895159A (en) | 1982-09-10 | 1990-01-23 | Weiss Jeffrey N | Diabetes detection method |
| US4883351A (en) | 1982-09-10 | 1989-11-28 | Weiss Jeffrey N | Apparatus for the detection of diabetes and other abnormalities affecting the lens of the eye |
| GB2163548B (en) | 1984-08-09 | 1987-11-25 | Perkin Elmer Ltd | Interferometric apparatus particularly for use in ft spectrophotometer |
| US4661706A (en) | 1985-02-25 | 1987-04-28 | Spectra-Tech Inc. | Blocker device for eliminating specular reflectance from a diffuse reflection spectrum |
| US4653880A (en) | 1985-03-01 | 1987-03-31 | Spectra-Tech Inc. | Reflective beam splitting objective |
| US4655225A (en) | 1985-04-18 | 1987-04-07 | Kurabo Industries Ltd. | Spectrophotometric method and apparatus for the non-invasive |
| US4730882A (en) | 1986-02-10 | 1988-03-15 | Spectra-Tech, Inc. | Multiple internal reflectance spectroscopy system |
| US4712912A (en) | 1986-03-10 | 1987-12-15 | Spectra-Tech, Inc. | Spectrophotometric image scrambler for full aperture microspectroscopy |
| JPS63252239A (ja) | 1987-04-09 | 1988-10-19 | Sumitomo Electric Ind Ltd | 反射型オキシメ−タ |
| US4853542A (en) | 1987-06-08 | 1989-08-01 | Nicolas J. Harrick | Collecting hemispherical attachment for spectrophotometry |
| US4857735A (en) | 1987-10-23 | 1989-08-15 | Noller Hans G | Light emitting diode spectrophotometer |
| JPH0827235B2 (ja) | 1987-11-17 | 1996-03-21 | 倉敷紡績株式会社 | 糖類濃度の分光学的測定法 |
| US4882492A (en) | 1988-01-19 | 1989-11-21 | Biotronics Associates, Inc. | Non-invasive near infrared measurement of blood analyte concentrations |
| US4859064A (en) | 1988-05-09 | 1989-08-22 | Spectra-Tech, Inc. | Diffuse reflectance spectroscopy system and method |
| EP0449883B1 (en) | 1988-12-21 | 1996-01-31 | Massachusetts Institute Of Technology | A method for laser induced fluorescence of tissue |
| US4975581A (en) | 1989-06-21 | 1990-12-04 | University Of New Mexico | Method of and apparatus for determining the similarity of a biological analyte from a model constructed from known biological fluids |
| US5007423A (en) | 1989-10-04 | 1991-04-16 | Nippon Colin Company Ltd. | Oximeter sensor temperature control |
| US5116919A (en) * | 1990-12-05 | 1992-05-26 | E. I. Du Pont De Nemours And Company | Process for increasing the relative viscosity of polyamides with reduced thermal degradation |
| US5203328A (en) | 1991-07-17 | 1993-04-20 | Georgia Tech Research Corporation | Apparatus and methods for quantitatively measuring molecular changes in the ocular lens |
| US5754716A (en) | 1992-02-07 | 1998-05-19 | Baxter International Inc. | Optical mode mixer using fiber optic bundle |
| US5370114A (en) | 1992-03-12 | 1994-12-06 | Wong; Jacob Y. | Non-invasive blood chemistry measurement by stimulated infrared relaxation emission |
| US5636633A (en) | 1995-08-09 | 1997-06-10 | Rio Grande Medical Technologies, Inc. | Diffuse reflectance monitoring apparatus |
| US6240309B1 (en) * | 1995-10-06 | 2001-05-29 | Hitachi, Ltd. | Optical measurement instrument for living body |
| US5725480A (en) * | 1996-03-06 | 1998-03-10 | Abbott Laboratories | Non-invasive calibration and categorization of individuals for subsequent non-invasive detection of biological compounds |
| EP0971624A1 (en) * | 1997-03-13 | 2000-01-19 | Biomax Technologies, Inc. | Methods and apparatus for detecting the rejection of transplanted tissue |
| US6124597A (en) * | 1997-07-07 | 2000-09-26 | Cedars-Sinai Medical Center | Method and devices for laser induced fluorescence attenuation spectroscopy |
| US7039446B2 (en) | 2001-01-26 | 2006-05-02 | Sensys Medical, Inc. | Indirect measurement of tissue analytes through tissue properties |
| US6070093A (en) * | 1997-12-02 | 2000-05-30 | Abbott Laboratories | Multiplex sensor and method of use |
| EP1051104B1 (en) | 1998-01-26 | 2008-04-09 | Massachusetts Institute Of Technology | Fluorescence imaging endoscope |
| US6728560B2 (en) | 1998-04-06 | 2004-04-27 | The General Hospital Corporation | Non-invasive tissue glucose level monitoring |
| US6721582B2 (en) * | 1999-04-06 | 2004-04-13 | Argose, Inc. | Non-invasive tissue glucose level monitoring |
| US20020091324A1 (en) | 1998-04-06 | 2002-07-11 | Nikiforos Kollias | Non-invasive tissue glucose level monitoring |
| US6505059B1 (en) | 1998-04-06 | 2003-01-07 | The General Hospital Corporation | Non-invasive tissue glucose level monitoring |
| AU766166B2 (en) * | 1998-04-06 | 2003-10-09 | General Hospital Corporation, The | Non-invasive tissue glucose level monitoring |
| US7899518B2 (en) | 1998-04-06 | 2011-03-01 | Masimo Laboratories, Inc. | Non-invasive tissue glucose level monitoring |
| WO1999057529A1 (en) | 1998-05-04 | 1999-11-11 | The Board Of Regents | Combined fluorescence and reflectance spectroscopy |
| US6332092B1 (en) | 1998-07-08 | 2001-12-18 | Lifespex, Incorporated | Optical probe having and methods for uniform light irradiation and/or light collection over a volume |
| EP2325622B1 (en) | 1998-08-26 | 2014-03-12 | Sensors for Medicine and Science, Inc. | Optical-based sensing device |
| AU6139199A (en) | 1998-09-11 | 2000-04-03 | Spectrx, Inc. | Multi-modal optical tissue diagnostic system |
| US6088606A (en) | 1999-03-22 | 2000-07-11 | Spectrx, Inc. | Method and apparatus for determining a duration of a medical condition |
| ES2326397T3 (es) | 1999-09-30 | 2009-10-08 | Diagnoptics Holding B.V. | Metodo y aparato para determinar autofluorescencia en los tejidos de la piel. |
| AU2001238517A1 (en) * | 2000-02-18 | 2001-08-27 | Argose, Inc. | Non-invasive tissue glucose level monitoring |
| WO2001061319A1 (en) | 2000-02-18 | 2001-08-23 | Argose, Inc. | Reduction of inter-subject variation via transfer standardization |
| JP2003522578A (ja) | 2000-02-18 | 2003-07-29 | アーゴス インク | 不均質組織における空間的に平均された励起−発光マップの生成 |
| US20020010401A1 (en) | 2000-05-18 | 2002-01-24 | Andrew Bushmakin | Pre- and post-processing of spectral data for calibration using mutivariate analysis techniques |
| JP2002095663A (ja) * | 2000-09-26 | 2002-04-02 | Fuji Photo Film Co Ltd | センチネルリンパ節光断層画像取得方法および装置 |
| US6615063B1 (en) * | 2000-11-27 | 2003-09-02 | The General Hospital Corporation | Fluorescence-mediated molecular tomography |
| US6609015B2 (en) * | 2001-01-18 | 2003-08-19 | Koninklijke Philips Electronics N.V. | Analysis of a composition |
| US6697652B2 (en) | 2001-01-19 | 2004-02-24 | Massachusetts Institute Of Technology | Fluorescence, reflectance and light scattering spectroscopy for measuring tissue |
| US6862091B2 (en) | 2001-04-11 | 2005-03-01 | Inlight Solutions, Inc. | Illumination device and method for spectroscopic analysis |
| US6865408B1 (en) | 2001-04-11 | 2005-03-08 | Inlight Solutions, Inc. | System for non-invasive measurement of glucose in humans |
| US7139598B2 (en) | 2002-04-04 | 2006-11-21 | Veralight, Inc. | Determination of a measure of a glycation end-product or disease state using tissue fluorescence |
| US6574490B2 (en) | 2001-04-11 | 2003-06-03 | Rio Grande Medical Technologies, Inc. | System for non-invasive measurement of glucose in humans |
| DE10163972B4 (de) * | 2001-12-22 | 2005-10-27 | Roche Diagnostics Gmbh | Verfahren und Vorrichtung zur Bestimmung eines Lichttransportparameters und eines Analyten in einer biologischen Matrix |
| US6684099B2 (en) | 2002-04-04 | 2004-01-27 | Inlight Solutions, Inc. | Apparatus and method for reducing spectral complexity in optical sampling |
| JP3647419B2 (ja) * | 2002-04-24 | 2005-05-11 | ショーワ株式会社 | 作業用手袋 |
| US7088495B2 (en) | 2002-06-03 | 2006-08-08 | Sparta, Inc. | Method and apparatus for time-division multiplexing to improve the performance of multi-channel non-linear optical systems |
| US20040068193A1 (en) * | 2002-08-02 | 2004-04-08 | Barnes Russell H. | Optical devices for medical diagnostics |
| US20040064053A1 (en) * | 2002-09-30 | 2004-04-01 | Chang Sung K. | Diagnostic fluorescence and reflectance |
| US7623906B2 (en) | 2002-11-12 | 2009-11-24 | Inlight Solutions, Inc | Diffuse reflectance spectroscopy |
| US8620411B2 (en) | 2003-12-12 | 2013-12-31 | Johnson & Johnson Consumer Companies, Inc. | Method of assessing skin and overall health of an individual |
| US9750449B2 (en) | 2003-12-12 | 2017-09-05 | Johnson & Johnson Consumer Inc. | Method of assessing skin |
| US7167736B2 (en) | 2004-11-04 | 2007-01-23 | Q Step Technologies, Inc. | Non-invasive measurement system and method for measuring the concentration of an optically-active substance |
| US7314982B2 (en) * | 2005-02-25 | 2008-01-01 | Stine Seed Farm, Inc. | Soybean cultivar 4817034 |
-
2004
- 2004-10-22 US US10/972,173 patent/US7139598B2/en not_active Expired - Fee Related
- 2004-10-26 CA CA2544204A patent/CA2544204C/en not_active Expired - Fee Related
- 2004-10-26 JP JP2006538173A patent/JP5053639B2/ja not_active Expired - Fee Related
- 2004-10-26 KR KR1020137002182A patent/KR20130014646A/ko not_active Withdrawn
- 2004-10-26 KR KR1020077011070A patent/KR101268428B1/ko not_active Expired - Fee Related
- 2004-10-26 CN CN201210184208.4A patent/CN102697510B/zh not_active Expired - Fee Related
- 2004-10-26 WO PCT/US2004/035462 patent/WO2005045393A2/en not_active Ceased
- 2004-10-26 EP EP04796435A patent/EP1686888A4/en not_active Withdrawn
-
2006
- 2006-05-03 US US11/417,463 patent/US8121671B2/en not_active Expired - Fee Related
- 2006-11-17 US US11/561,380 patent/US8078243B2/en not_active Expired - Fee Related
-
2007
- 2007-04-27 JP JP2007119053A patent/JP5053699B2/ja not_active Expired - Fee Related
-
2011
- 2011-11-09 US US13/292,321 patent/US20120065484A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US7139598B2 (en) | 2006-11-21 |
| KR20070054761A (ko) | 2007-05-29 |
| JP2007510159A (ja) | 2007-04-19 |
| EP1686888A4 (en) | 2011-01-05 |
| US20070088205A1 (en) | 2007-04-19 |
| JP5053699B2 (ja) | 2012-10-17 |
| KR20130014646A (ko) | 2013-02-07 |
| CA2544204C (en) | 2013-07-09 |
| CN102697510A (zh) | 2012-10-03 |
| WO2005045393A2 (en) | 2005-05-19 |
| CN102697510B (zh) | 2015-10-21 |
| CA2544204A1 (en) | 2005-05-19 |
| US8121671B2 (en) | 2012-02-21 |
| EP1686888A2 (en) | 2006-08-09 |
| KR101268428B1 (ko) | 2013-06-04 |
| US20120065484A1 (en) | 2012-03-15 |
| US20060211928A1 (en) | 2006-09-21 |
| HK1103004A1 (en) | 2007-12-14 |
| WO2005045393A3 (en) | 2005-09-15 |
| US8078243B2 (en) | 2011-12-13 |
| US20050148834A1 (en) | 2005-07-07 |
| JP2007222669A (ja) | 2007-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5053699B2 (ja) | 組織の蛍光発光を用いた糖化最終産物または疾病状態の尺度の決定 | |
| US8238993B2 (en) | Determination of a measure of a glycation end-product or disease state using tissue fluorescence lifetime | |
| CN100998499B (zh) | 使用组织荧光确定某一糖化终产物或疾病状态 | |
| US7725144B2 (en) | Determination of disease state using raman spectroscopy of tissue | |
| US20120078075A1 (en) | Determination of a measure of a glycation end-product or disease state using tissue fluorescence in combination with one or more other tests | |
| KR20120130164A (ko) | 관상 동맥 석회화 또는 질병을 검출하는 방법 및 장치 | |
| CN101716069A (zh) | 人体氧化应激无创荧光检测装置与方法 | |
| WO2009086473A1 (en) | Improved method and apparatus for determination of a measure of a glycation end-product or disease state using tissue fluorescence | |
| Georgakoudi et al. | Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in patients with Barrett's esophagus | |
| WO2006009910A2 (en) | Time-resolved optometric fluorescence detection for skin diagnostics | |
| WO2009086474A2 (en) | Method and apparatus to compensate for melanin and hemoglobin variation in determination of a measure of a glycation end-product or disease state using tissue fluorescence | |
| US20070156036A1 (en) | Time-resolved non-invasive optometric device for detecting diabetes | |
| Graaff et al. | Instrumentation for the measurement of autofluorescence in human skin | |
| JP2004321325A (ja) | 血糖値の定量方法 | |
| KR20070017479A (ko) | 조직 형광을 이용한, 당화 최종산물 또는 질병 상태 측정의판정방법 | |
| HK1176846A (en) | Determination of a measure of a glycation end-product or disease state using tissue fluorescence | |
| HK1103004B (en) | Determination of a measure of a glycation end-product or disease state using tissue fluorescence | |
| HK1098940A (en) | Determination of a measure of a glycation end-product or disease state using tissue fluorescence | |
| AU2024294263A1 (en) | Production and testing of a multivariate analysis model in measurement of analyte using spectroscopic techniques | |
| KR20160019776A (ko) | 비침습 간기능 검사 장치 및 비침습 간기능 검사 방법 | |
| HK1155052A (en) | Improved method and apparatus for determination of a measure of a glycation end-product or disease state using tissue fluorescence |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070730 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070827 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100427 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100727 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100729 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100803 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110215 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110427 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111101 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120201 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120724 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120726 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5053639 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150803 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |